Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.20
BATS BZX Real-Time Price
As of 1:08pm ET
 +0.07 / +6.19%
Today’s Change
0.88
Today|||52-Week Range
7.69
-48.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$18.2M

Company Description

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in Los Gatos, CA.

Contact Information

Aridis Pharmaceuticals, Inc.
983 University Avenue
Los Gatos California 95032
P:(408) 385-1742
Investor Relations:
(970) 987-2654

Employees

Shareholders

Individual stakeholders8.17%
Mutual fund holders6.44%
Other institutional5.23%

Top Executives

Vu L. TruongDirector, Chief Executive & Scientific Officer
Fred KurlandChief Financial & Accounting Officer
Hasan JafriChief Medical Officer
Steven M. ChamowVice President-Research & Development
Lisa SherHead-Investor & Public Relations